The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

ROCK veteran Ozzy Osbourne will play his final EVER show this summer, amid his worsening battle with Parkinson’s disease. The ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...